BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,872 | -64.7% | 11,412 | -7.0% | 0.00% | – |
| Q2 2023 | $81,685 | -63.8% | 12,265 | +1.3% | 0.00% | -100.0% |
| Q1 2023 | $225,842 | -6.0% | 12,103 | +8.2% | 0.00% | 0.0% |
| Q4 2022 | $240,189 | +172.9% | 11,182 | +50.0% | 0.00% | 0.0% |
| Q3 2022 | $88,000 | -15.4% | 7,456 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $104,000 | -39.5% | 7,851 | -4.3% | 0.00% | 0.0% |
| Q1 2022 | $172,000 | +0.6% | 8,204 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $171,000 | -32.7% | 8,435 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $254,000 | +66.0% | 8,380 | +58.7% | 0.00% | 0.0% |
| Q2 2021 | $153,000 | -30.1% | 5,280 | +3.9% | 0.00% | 0.0% |
| Q1 2021 | $219,000 | +157.6% | 5,083 | +176.9% | 0.00% | 0.0% |
| Q4 2020 | $85,000 | +6.2% | 1,836 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $80,000 | – | 1,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |